AI assistant
Sending…
Edesa Biotech, Inc. — Director's Dealing 2018
Jan 25, 2018
35006_dirs_2018-01-25_bb7c59c7-8828-414e-a47f-dfad067519c6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Stellar Biotechnologies, Inc. (SBOT)
CIK: 0001540159
Period of Report: 2018-01-23
Reporting Person: Aghib Deborah F. (Director)
More from Edesa Biotech, Inc.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Regulatory Filings
2026
Feb 24
Interim / Quarterly Report
2026
Feb 13